. 2022 Jul 1;26(7):567–576. doi: 10.5152/AnatolJCardiol.2022.1597
Content of this journal is licensed under a Table 6.
Hemogram and Biochemical Parameter Results
| CHA2DS2-VASc Score Risk Classification | Low-Medium Risk (n = 349) | High Risk (n = 2243) | Total (n = 2592) | P |
|---|---|---|---|---|
| Hg (gr/dL) | 13.8 ± 1.8 | 12.8 ± 1.8 | 13.0 ± 1.9 | <.001 |
| Hct (%) | 41.7 ± 4.8 | 39.6 ± 5.1 | 39.9 ± 5.1 | <.001 |
| Plt (103/µL) | 236 ± 70.4 | 235.5 ± 73.9 | 235 ± 70.9 | .914 |
| WBC, (103/µL) | 8.0 ± 2.5 | 7.9 ± 2.4 | 7.9 ± 2.4 | .416 |
| Neutrophil (%) | 59.8 ± 9.9 | 63.6 ± 10.3 | 63 ± 10.3 | <.001 |
| Lymphocyte (%) | 28.4 ± 8.9 | 25.4 ± 9.0 | 25.8 ± 9.0 | <.001 |
| Monocyte (%) | 7.2 ± 2.9 | 7.3 ± 2.7 | 7.3 ± 2.8 | .414 |
| MPV (%) | 9.0 ± 1.4 | 9.2 ± 1.5 | 9.2 ± 1.5 | .026 |
| Glucose (mg/dL) | 103.3 ± 22.7 | 120.7 ± 42.8 | 118 ± 41 | <.001 |
| Urea (mg/dL) | 29.1 ± 12.2 | 33.8 ± 15.6 | 33 ± 15.3 | <.001 |
| Creatinine (mg/dL) | 0.81 (0.71-1.0) | 0.9 (0.74-1.1) | 0.9 (0.74-1.1) | <.001 |
| ALT (U/L) | 19 (15-26) | 18 (13-25) | 18 (13-25) | <.001 |
| AST (U/L) | 22 (17-30) | 21 (17-28) | 21 (17-28) | .026 |
| Albumin (gr/dL) | 4.1 ± 0.5 | 4.0 ± 0.5 | 4.0 ± 0.5 | .092 |
| Total cholesterol (mg/dL) | 177.6 ± 42.2 | 179.4 ± 43.9 | 179 ± 43.7 | .474 |
| Triglyceride (mg/dL) | 135.3 ± 66.6 | 131.5 ± 61.6 | 132 ± 62.3 | .288 |
| LDL (mg/dL) | 110 ± 38 | 108.8 ± 35.2 | 109 ± 35.6 | .580 |
| HDL (mg/dL) | 42.8 ± 10.6 | 44.2 ± 12.2 | 44 ± 12.0 | .051 |
| Uric acid (mg/dL) | 6 (4.8-7) | 6.1 (5.1-7.5) | 6.1 (5.0-7.4) | <.001 |
P value of <.05 shows statistical significance.
Hg, hemoglobin; Hct, hematocrit; Plt, platelet; WBC, white blood cell; MPV, mean platelet volume; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDL, low-density lipoprotein; HDL, high-density lipoprotein.